Maghanoy, Mel Jairus S.
HRN: 21-81-47 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/17/2022
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
08/17/2022
08/23/2022
ORAL
4ml
TID
Acute Gastritis, URTI
Waiting Final Action
Indication: Empiric Type of Infection: URTIIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes